Micro Interventional Devices: Neovasc inks $3m settlement deal with MID, raises $1m

Neovasc (NSDQ:NVCN) said today that it inked a $3 million settlement agreement with Micro Interventional Devices to resolve undisclosed allegations related to Neovasc's transcatheter mitral valve replacement technology, including its flagship Tiara device, and added that it has raised approximately $1.2 million. The agreement includes payments totally approximately $3 million to be made by Neovasc to [...]The post Neovasc inks $3m settlement deal with MID, raises $1m appeared first on MassDevice.